Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection

Recruiting Observational Study
COVID-19
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
Juan Kang · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
With the decline of virulence after the mutation of the SARS-CoV-2 , based on the national life and health and national development needs, the domestic SARS-CoV-2 infection epidemic prevention policy has changed, and the number of people infected by the SARS-CoV-2 has increased. Nutritional status is an indicator of human health and plays an important role in fighting disease. Malnutrition has bee…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients with a positive SARS-CoV-2 nucleic acid test or a positive SARS-CoV-2 antigen test. Exclusion Criteria: 1. People with end-stage malignant tumors; 2. Nutritional intake disorders, mainly dependent on enteral and parenteral nutrition supporters; 3. paralyzed; 4. Intrav…
Contacts

Juan Kang, M.D.

8613996112052

68368892@qq.com

CONTACT